Almost all people who received in-hospital treatment for a gout flare were using urate-lowering therapy within 6 months of discharge after a multifaceted intervention with nurse-led follow-up.
The British Society for Rheumatology and the British Association of Dermatologists developed guidelines for the management of people living with Behçet's disease.
NICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people.